| Detailed information |
|---|
| CancerLivER ID | 2133 |
| Biomarker | miR-1 |
| Biomarker Name/Symbol (given in Publication) | miR-1 |
| Biomolecule | miRNA |
| Subject | Human |
| Degree of Validity | miR-1 is a new independent parameter of OS in HCC patients; but not validated on independent dataset |
| Experimental Condition | HCC v/s Liver Cirrhosis; predict survival of patients |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Increasead concentration showed longer OS in HCC |
| Level of significance | p < 0.01 |
| Source | Serum |
| PMID | 23810247 |
| Type of Biomarker | Prognostic |
| Pathway | NA |
| Cohort | 195 sera of HCC patients and 54 patients with liver cirrhosis |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCC, liver Cirrhosis |
| Year of Publication | 2013 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |